You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 23, 2024

Thioridazine - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for thioridazine and what is the scope of patent protection?

Thioridazine is the generic ingredient in four branded drugs marketed by Novartis, Actavis Mid Atlantic, Alpharma Us Pharms, Ani Pharms, Epic Pharma Llc, Pharm Assoc, Sandoz, Wockhardt, Roxane, Chartwell Rx, Heritage Pharma Avet, Mutual Pharm, Mylan, Par Pharm, Sun Pharm Industries, Superpharm, Watson Labs, Watson Labs Teva, and West Ward, and is included in eighty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for thioridazine.

Summary for thioridazine

US Patents:	0
Tradenames:	4
Applicants:	19
NDAs:	81
Drug Master File Entries:	18
Raw Ingredient (Bulk) Api Vendors:	60
Clinical Trials:	10
Patent Applications:	7,071
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for thioridazine
DailyMed Link:	thioridazine at DailyMed

See drug prices for thioridazine

Recent Clinical Trials for thioridazine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Rambam Health Care Campus	Early Phase 1
Rabin Medical Center	Early Phase 1
Astellas Pharma Inc	Phase 4

See all thioridazine clinical trials

Medical Subject Heading (MeSH) Categories for thioridazine

Antipsychotic Agents
Dopamine Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for thioridazine

N05AC	Phenothiazines with piperidine structure
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for thioridazine

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	THIORIDAZINE HYDROCHLORIDE	thioridazine hydrochloride	TABLET;ORAL	088004-002	Mar 15, 1983		RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	MELLARIL	thioridazine hydrochloride	TABLET;ORAL	011808-006	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	MELLARIL	thioridazine hydrochloride	TABLET;ORAL	011808-009	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.